They expressed gratitude for being granted the opportunity to perform and complete the haj this year.

Discover how the Completed Contract Method in accounting defers revenue and expenses until project completion, useful for ...

Polito's book accepts the common idea that Dylan lost his way in the 1980s, putting out mediocre music and giving listless live performances. I'd certainly noticed that something was up when Dylan ...

According to a revised black box warning for capecitabine (Xeloda), patients should be tested for genetic variants of the DPYD gene prior to starting capecitabine unless immediate treatment is ...

In a phone interview with CBS News on Monday afternoon, President Trump said the U.S. war with Iran could almost be over. "I think the war is very complete, pretty much," the president said, speaking ...

Bob covers the money in health care, focusing on health insurance and hospitals. His stories delve into Medicare Advantage, opaque prescription drug benefits, and how much executives actually make. He ...

The FDA added a boxed warning to capecitabine and 5-FU labels, noting the risk of serious adverse reactions or death in patients with complete DPD deficiency. Capecitabine and 5-FU are both nucleoside ...

Oncology specialists should inform patients about a risk of serious toxicity related to dihydropyrimidine dehydrogenase (DPD) deficiency and should test for DPYD variants before starting treatment ...

The FDA has updated the product labeling of capecitabine (Xeloda, Genentech) and fluorouracil to reflect the risks of acute toxicity and potentially fatal adverse reactions in patients with ...

Xeloda (capecitabine) is a prescription chemotherapy drug that’s used to treat different types of cancer in adults. As with other drugs, it can cause side effects that range from mild to serious. Most ...

IKEv1's DPD (Dead Peer Detection) and IKEv2's LIVENESS mechanism are very different beasts. But so is how Libreswan v3/v4, and v5 implemented these features. Consequently when migrating from a v3 or ...